42
Participants
Start Date
August 31, 1999
Primary Completion Date
December 31, 2006
Study Completion Date
September 30, 2013
Rituximab
375 mg/m\^2 by vein once a week for 4 weeks on Days 1, 8, 15, 22.
GM-CSF
250 mcg subcutaneously 3 times a week for 8 weeks.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Genentech, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER